InnovaMatrix® AC
InnovaMatrix® AC is the first FDA-cleared placental-derived extracellular matrix medical device for wound management.1
InnovaMatrix® AC is a placental-derived device that preserves the inherent structural benefits of the placenta while adding the reliability, reproducibility, and safety profile of a medical device.2,3,4
InnovaMatrix® AC is indicated for the management of wounds including*:
- Partial and full-thickness wounds
- Pressure ulcers
- Venous ulcers
- Diabetic ulcers
- Chronic vascular ulcers
- Tunneled/undermined wounds
- Surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound
dehiscence) - Trauma wounds (abrasions, lacerations, and skin tears)
- Partial-thickness second degree burns
- Draining wounds
This device is intended for one-time use.
;
Available Sizes
Size |
Product Number |
|
15 mm Disc |
IMX-15MM-01 |
|
2 cm x 2 cm |
IMX-0202-01 |
|
4 cm x 4 cm |
IMX-0404-01 |
|
4 cm x 6 cm |
IMX-0406-01 |
|
5 cm x 5 cm |
IMX-0505-01 |
Contraindications
This device is derived from porcine collagen and should not be used on patients with sensitivity or allergy to porcine materials; sensitivity or allergy to collagen; or active or latent infection in or around the application site.
This device is not indicated for use in third degree burns.
Coverage and Reimbursement Support
We partner with our customers to provide reimbursement support, including insurance verifications, payor trends, and claims and prior authorization support.
Need Help?
Contact us: 888-767-4849 or reimbursement.wound@convatec.com
Request a sample of our product
You might be interested in…
References
*See package insert for full list of indications.
- 510K Product Code history
- RDR-002
- Badylak MEMO-001
- K193552 510K Summary